L-arginine stimulates an endogenous ADP-ribosyltransferase.
An ubiquitous biochemical pathway known to synthesize nitric oxide (NO) from L-arginine has been identified in many cell types. Recent studies indicate that besides activating soluble guanylate cyclase NO is likely to have effects unrelated to the known signal transduction pathway. Activation of the soluble NO synthase stimulates an endogenous ADP-ribosylation of a predominant 39 kDa protein, known to be activated by NO releasing agents. This is demonstrated using the cytosolic fraction of rat cerebellum and HL-60 cells. The ADP-ribosylation is suppressed by the known NO synthase inhibitors N-nitro-L-arginine and N-methyl-L-arginine. These observations indicate that NO derived from its physiological precursor L-arginine activates an endogenous ADP-ribosyltransferase.
Dimmeler
S
S
Faculty of Biology, Department of Biological Chemistry, University of Konstanz, F.R.G.
Brüne
B
B
D000818:Animals; D001120:Arginine / Q000494:pharmacology*; D002460:Cell Line; D002531:Cerebellum / Q000201:enzymology*; D003600:Cytosol / Q000201:enzymology; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D007700:Kinetics; D015473:Leukemia, Promyelocytic, Acute; D009243:NAD / Q000378:metabolism; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism*; D051381:Rats
D009243:NAD; D001120:Arginine; D011065:Poly(ADP-ribose) Polymerases